Yongjun Dang

7.7k total citations · 4 hit papers
101 papers, 5.2k citations indexed

About

Yongjun Dang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yongjun Dang has authored 101 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Cell Biology. Recurrent topics in Yongjun Dang's work include Ubiquitin and proteasome pathways (10 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and RNA Research and Splicing (9 papers). Yongjun Dang is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and RNA Research and Splicing (9 papers). Yongjun Dang collaborates with scholars based in China, United States and South Korea. Yongjun Dang's co-authors include Jun O. Liu, Shridhar Bhat, Tilman Schneider‐Poetsch, William C. Merrick, Woon‐Kai Low, Daniel Romo, Rachel Green, Jianhua Ju, Daniel E. Eyler and Ben Shen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yongjun Dang

96 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

2010 717 citations Tilman Schneider‐Poetsch, Jianhua Ju et al. profile →
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

2016 563 citations Xuguang Yang, Yuli Lin et al. Cancer Research profile →
Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation

2021 183 citations Yongjun Dang et al. profile →
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction

2024 53 citations Yang Liu, Jingjing Jiang et al. Science profile →

Peers

Countries citing papers authored by Yongjun Dang

Since Specialization

Citations

This map shows the geographic impact of Yongjun Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Dang more than expected).

Fields of papers citing papers by Yongjun Dang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjun Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Dang. The network helps show where Yongjun Dang may publish in the future.

Co-authorship network of co-authors of Yongjun Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjun Dang. A scholar is included among the top collaborators of Yongjun Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjun Dang. Yongjun Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Remodeling of senescent macrophages in synovium alleviates trauma- and aging-induced osteoarthritis 2025 ·Bioactive Materials ·Yuhang Liu, (unknown), Yongjun Dang, (unknown), (unknown), (unknown), Ruijue Wang, Yuhan Li, Song Zhang, (unknown), Jia Lv, (unknown), Xiaoling Zhang, Yiyun Cheng	1
2	Nitrogen-Doped Carbon Dots Alleviate Pesticide Toxicity in Tomato by Regulating Antioxidant Systems 2025 ·International Journal of Molecular Sciences ·Xu Zhang, Xin Yu, Hao Wang, Yongjun Dang, Wenhui Wang, Yi Gao, Han Yu, Ran Kang, Qinghua Shi, (unknown)	0
3	Biochemical analysis of PD-L1 ubiquitination by CRL3SPOP, ARIH1, and NEDD4 family ubiquitin ligases 2025 ·Structure ·Guomin Xie, Lin Gao, Ruifang Lu, (unknown), Tiantian Zheng, Xinning Li, Yongjun Dang, Philip A. Cole, Xianjun Yu, Hanjie Jiang, Zan Chen	1
4	LigDockTailor: Ligand-specific docking tool matching using multidimensional descriptors 2025 ·Computational Biology and Chemistry ·Kai Zhang, (unknown), (unknown), (unknown), (unknown), Yueyang Wang, (unknown), Linyu Yu, Sirui Chen, Shiyong Ma, Kongkai Zhu, Bowen Ke, Jiaxue Wu, Zufeng Guo, Ling Zhang, Yongjun Dang, Junchi Hu	0
5	Girolline is a sequence context-selective modulator of eIF5A activity 2025 ·Nature Communications ·Tilman Schneider‐Poetsch, Yongjun Dang, W. Iwasaki, (unknown), Yuichi Shichino, Ali Al‐Mourabit, (unknown), Daniel Romo, Jun O. Liu, Takuhiro Ito, Shintaro Iwasaki, Minoru Yoshida	0
6	Adenanthin exhibits anti-inflammatory effects by covalently targeting the p65 subunit in the NF-κB signaling pathway 2024 ·European Journal of Medicinal Chemistry ·Tong Lu, (unknown), (unknown), Haiyang Li, Le Kuai, (unknown), Yongjun Dang, Qunfei Zhao, Rijing Liao, (unknown), Qingli He	2
7	Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction breakdown → 2024 ·Science ·Yang Liu, Jingjing Jiang, (unknown), Liangshan Mu, (unknown), (unknown), Ye Yao, Meng Ding, (unknown), Qiuhan Yu, (unknown), Hongyu Xu, (unknown), Shuwen Qian, Yan Tang, Wei Li, Yongjun Dang, Xi Dong, (unknown), Congjian Xu, Qi‐Qun Tang	53
8	m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation 2024 ·Oncogene ·Yujiao Liu, Jia Li, Jie Xu, (unknown), Yuan Wang, (unknown), Junchi Hu, Qinglv Wei, Qingya Luo, (unknown), (unknown), (unknown), Yang Yu, Yongjun Dang, Jing Xu, Tao Liu, Ping Yi	11
9	Marine-Derived Natural Product HDYL-GQQ-495 Targets P62 to Inhibit Autophagy 2023 ·Marine Drugs ·Quanfu Li, (unknown), (unknown), (unknown), (unknown), Wei Jiang, Dehai Li, Yongjun Dang	2
10	L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), Xiaobo Wang, Bing Li, (unknown), Ruina Wang, Hongru Tao, Junchi Hu, Yu Jin, Hualiang Jiang, Kaixian Chen, Cheng Luo, Yongjun Dang, Yuanyuan Zhang	17
11	Suppression of toxicity of the mutant huntingtin protein by its interacting compound, desonide 2022 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Chenggang Zhu, Ziying Wang, (unknown), Peng Wu, (unknown), Juan Botas, Yongjun Dang, Yu Ding, Yiyan Fei, Boxun Lu	7
12	Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis 2022 ·Life Science Alliance ·Tianxiang Wang, (unknown), (unknown), (unknown), (unknown), Yongjun Dang, Ao Zhang, Yue Xiong, Chunyong Ding, Kun‐Liang Guan, Hai‐Xin Yuan	29
13	FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis 2022 ·Nature Communications ·(unknown), Ling Wu, Christoph Block, Mu Zhang, Justin Hackett, Douglas B. Craig, Wei Chen, Yongzhong Zhao, Bin Zhang, Yongjun Dang, Xiaohong Zhang, Shengping Zhang, Chuangui Wang, Heather M. Gibson, Lori A. Pile, Benjamin L. Kidder, Larry H. Matherly, Zhe Yang, Yali Dou, Guojun Wu	24
14	Synthesis of Sea Cucumber Saponins with Antitumor Activities 2020 ·The Journal of Organic Chemistry ·(unknown), Xiaobo Wang, (unknown), Yongjun Dang, Biao Yu	11
15	NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2 2020 ·Cell Death Discovery ·Donglin Ding, Huixing Huang, Quanfu Li, Wenbo Yu, Chenji Wang, Haijie Ma, Jiaxue Wu, Yongjun Dang, Long Yu, Wei Jiang	5
16	p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization 2019 ·Theranostics ·(unknown), Jiacheng Li, Jing Huang, Pan Xu, (unknown), Y. Liu, Yu Liang, Yaxi Yang, (unknown), Hualiang Jiang, Kaixian Chen, Yongjun Dang, Yuanyuan Zhang, Cheng Luo, (unknown)	73
17	Synthesis and antiproliferative activities of OSW-1 analogues bearing 2-acylamino-xylose residues 2019 ·Organic Chemistry Frontiers ·Lijun Sun, Ruina Wang, Xiaobo Wang, Yongjun Dang, Wei Li, Biao Yu	8
18	Amino Acid Conjugated Anthraquinones from the Marine-Derived Fungus Penicillium sp. SCSIO sof101 2017 ·Journal of Natural Products ·Minghe Luo, (unknown), Hongbo Huang, (unknown), Aijun Sun, Yongjun Dang, (unknown), Jianhua Ju	30
19	FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling breakdown → 2016 ·Cancer Research ·Xuguang Yang, Yuli Lin, Yongyong Shi, Bingji Li, Weiren Liu, Wei Yin, Yongjun Dang, Yiwei Chu, Jia Fan, Rui He	563
20	Substrate-Dependent Targeting of Eukaryotic Translation Initiation Factor 4A by Pateamine A: Negation of Domain-Linker Regulation of Activity 2007 ·Chemistry & Biology ·Woon‐Kai Low, Yongjun Dang, Shridhar Bhat, Daniel Romo, Jun O. Liu	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact